Catalysts for Sigmapharm Laboratories LLC
16 tracked
Mar 27, 2026
approval
ASENAPINE MALEATE — FDA approval
ASENAPINE MALEATE
→
Feb 17, 2026
approval
AMBRISENTAN — FDA approval
AMBRISENTAN
→
Jan 18, 2026
approval
AMBRISENTAN — FDA approval
Sigmapharm Laboratories LLC
→
Jan 18, 2026
approval
AMBRISENTAN — FDA approval
Sigmapharm Laboratories LLC
→
Apr 4, 2025
approval
AMBRISENTAN — FDA approval
Sigmapharm Laboratories LLC
→
Apr 4, 2025
approval
AMBRISENTAN — FDA approval
AMBRISENTAN
→
Aug 19, 2024
approval
AMBRISENTAN — FDA approval
Sigmapharm Laboratories LLC
→
Aug 19, 2024
approval
AMBRISENTAN — FDA approval
AMBRISENTAN
→
Jun 8, 2021
approval
AMBRISENTAN — FDA approval
Sigmapharm Laboratories LLC
→
Jun 8, 2021
approval
AMBRISENTAN — FDA approval
AMBRISENTAN
→
Dec 22, 2020
approval
AMBRISENTAN — FDA approval
Sigmapharm Laboratories LLC
→
Dec 22, 2020
approval
AMBRISENTAN — FDA approval
AMBRISENTAN
→
Dec 10, 2020
approval
ASENAPINE MALEATE — FDA approval
ASENAPINE MALEATE
→
Nov 6, 2019
approval
AMBRISENTAN — FDA approval
Sigmapharm Laboratories LLC
→
Apr 10, 2019
approval
AMBRISENTAN — FDA approval
AMBRISENTAN
→
Mar 28, 2019
approval
AMBRISENTAN — FDA approval
Sigmapharm Laboratories LLC
→